MURRAY HILL, N.J.--(BUSINESS WIRE)--Jan. 20, 2004--C. R. Bard, Inc. (NYSE:BCR) today announced the appointment of John A. DeFord, Ph.D., to the position of vice president, science and technology, effective immediately. In his new role, Dr. DeFord will have oversight of Bard's research and new product development program.

Dr. DeFord joins Bard from Early Stage Partners, a venture capital fund based in Cleveland, OH, where he was a managing director, responsible for life sciences investments. Previously, he spent 8 years with Cook Incorporated, where, in 2001 he was named president and chief executive officer. Dr. DeFord received a B.S. and M.S. degree in electrical engineering and a Ph.D. in electrical/biomedical engineering, all from Purdue University. He has conducted extensive research and authored numerous scientific and business publications throughout his career.

"We are delighted to have John as part of our management team," commented Bard Chairman and Chief Executive Officer, Timothy M. Ring. "He brings a wealth of experience and talent, and we look forward to the impact John will have on Bard's growing research and development program."

C.R. Bard, Inc. (www.crbard.com), headquartered in Murray Hill, NJ, is a leading multinational developer, manufacturer, and marketer of innovative, life-enhancing technologies in the fields of vascular, urology, oncology, and surgical specialty products.

    CONTACT: C. R. Bard, Inc., Murray Hill
             Media:
             Holly P. Glass, 703-754-2848
                 or
             Investors:
             Eric J. Shick, 908-277-8143

    SOURCE: C. R. Bard, Inc.